Protein tyrosine phosphatase-prl-1 a a marker and therapeutic target for pancreatic cancer
申请人:Farnsworth L Amanda
公开号:US20070026398A1
公开(公告)日:2007-02-01
Using gene expression profiling, the present Invention identifies Protein tyrosine phosphatase IVA member 1 (PRL-1) as a diagnostic marker and therapeutic target for pancreatic cancer. The Invention therefore provides methods for prediction and detection of PRL-1 associated cancers, and evaluation of inhibitors of PRL-1. The Invention also provides a method of treating or preventing pancreatic cancer in a subject.